A bad air day may have consequences beyond coughing or irritated eyes.
New research from South Korea suggests that people with rheumatoid arthritis may experience more active disease after spending time in air with higher levels of fine particle pollution.
The clearest signal came from PM2.5, a form of pollution made up of particles so small that they can reach deep into the lungs.
Rheumatoid arthritis is very different from the common wear-and-tear arthritis that develops with age. In RA, the immune system becomes overactive and attacks the body’s own joints. This causes inflammation that can lead to pain, morning stiffness, swelling and, over time, permanent damage.
Many people with RA have periods when symptoms are relatively quiet followed by flare-ups when pain and inflammation become worse. Medicines can reduce these flares, but they do not explain why symptoms sometimes suddenly increase. Researchers have been looking at sleep, stress, infections, smoking and environmental exposures as possible triggers.
Air pollution has become one area of growing interest. Fine particles are produced by vehicle exhaust, industry, fires, fuel burning and other sources. Because these particles are extremely small, they can enter the lungs easily and may set off inflammatory reactions that reach far beyond the respiratory system.
Researchers wanted to know whether that inflammation could matter for people who already have RA. They followed 1,070 patients treated at a large medical center in South Korea from 2021 through 2024. Over those four years, the study included 12,583 clinic visits, allowing the team to compare changes in symptoms with changes in air quality over time.
For each patient, the researchers estimated exposure to six major air pollutants. They looked at sulfur dioxide, nitrogen dioxide, ozone, carbon monoxide, PM10 and PM2.5. They then compared recent pollution levels with measures of RA activity recorded during medical appointments.
The strongest and most consistent relationship involved PM2.5. When these fine particles were present at higher levels, patients tended to have more active RA and a greater chance of a flare. Exposure over more than two weeks appeared particularly important.
That timing may offer a clue about how pollution affects the immune system. Rather than causing an instant reaction, repeated exposure might gradually increase inflammation until symptoms become more noticeable. This idea fits with research showing that air pollution can create oxidative stress and disturb normal immune responses.
Oxidative stress happens when harmful reactive molecules build up faster than the body can control them. These molecules can damage proteins, fats and DNA, while also activating pathways that promote inflammation. In someone with an autoimmune disease such as RA, that extra inflammatory pressure could potentially make an already overactive immune system harder to control.
The researchers tried to separate the effect of pollution from other influences. Their calculations took account of factors such as demographics, RA-related antibodies, medicines, socioeconomic conditions and weather. They also used a study design that compared different periods within the same person, which can help reduce the effect of personal characteristics that stay relatively stable.
The research drew attention from experts because it moves beyond the question of whether pollution contributes to developing RA. Instead, it asks whether polluted air can affect the course of the disease after someone has already been diagnosed. That distinction matters because it opens the possibility that pollution exposure could be treated as a manageable part of flare prevention.
Jeffrey Sparks of Mass General Brigham and Harvard Medical School wrote in an accompanying editorial that the findings have clinical, biological and public-health importance.
He noted that worsening air pollution could have broad implications for RA and perhaps for other autoimmune diseases as well. For patients, poor air quality might help explain some flare-ups that otherwise seem to appear without an obvious reason.
The researchers suggested that people with RA may want to avoid prolonged exposure during periods of high PM2.5. That could mean checking local air-quality reports, reducing outdoor activity near busy roads when pollution is high, or improving indoor air filtration when practical. However, these actions have not yet been proven to reduce RA disease activity.
The study also has limits. It cannot show with certainty that PM2.5 caused the flares because people were not randomly assigned to breathe cleaner or dirtier air. Pollution exposure was estimated from monitoring data, which may not perfectly match what each patient actually breathed at home, at work or while traveling.
Another limitation is that all participants came from South Korea. Genetics, pollution sources, healthcare systems and daily lifestyles differ between countries. As Josef Smolen, editor-in-chief of the Annals of the Rheumatic Diseases, noted, the results need to be tested in other populations before they can be applied everywhere.
Even with those cautions, the study is strong because it followed the same patients repeatedly and used more than 12,000 real-world medical visits. The finding that PM2.5 remained important after several statistical checks makes the signal harder to dismiss as a simple coincidence. What remains uncertain is whether reducing exposure will actually lead to fewer flares.
The research was published in the Annals of the Rheumatic Diseases, the EULAR Journal, by Elsevier. The study adds to growing evidence that the air people breathe may influence diseases throughout the body, not just conditions of the lungs and heart.
The most useful conclusion is not that people with RA should fear every polluted day, but that air quality may be one more piece of a complicated disease puzzle.
If future studies confirm that reducing PM2.5 lowers disease activity, cleaner air could become a practical addition to medicines, exercise and other parts of RA care. The findings also strengthen the public-health argument for reducing fine-particle pollution for everyone, not only people with arthritis.
If you care about health, please read studies that vegetarian women have higher risk of hip fracture, and these vitamins could help reduce bone fracture risk.
For more health information, please see recent studies that Krill oil could improve muscle health in older people, and Jarlsberg cheese could help prevent bone thinning disease.
Source: Seoul National University.
